What is it?
When BPA was restricted from baby bottles and food contact materials under public and regulatory pressure, manufacturers replaced it with structurally similar compounds, primarily BPS (bisphenol S), BPF (bisphenol F), and BPAF (bisphenol AF). These alternatives were adopted on the basis that limited safety data existed at the time of substitution. The research that has since accumulated shows a consistent pattern: BPA analogues activate oestrogen receptors, disrupt thyroid signalling, and cause reproductive harm at similar or lower concentrations than BPA. The phrase "BPA-free" has become a marketing claim rather than a safety one.
What it does to your body
Oestrogen receptor activation
BPS and BPF bind to oestrogen receptors with affinity comparable to BPA. BPAF has been found to bind with greater potency than BPA in some assays.
Thyroid disruption
BPS and BPF interfere with thyroid hormone signalling. Some studies show more potent effects on thyroid function than BPA.
Reproductive harm
Animal studies show BPS alters ovarian follicle development and disrupts reproductive cycles at concentrations similar to BPA.
Metabolic disruption
BPA alternatives have been linked to insulin resistance and adipogenesis in cell studies, suggesting similar metabolic risks to BPA.
Environmental persistence
BPS is more resistant to biodegradation than BPA and has been detected in river sediments, freshwater fish and human breast milk.
How widespread is the problem?
Studies published after the BPA phase-out have found BPS in the urine of 81% of Americans sampled, and BPF in 67%, indicating near-universal exposure. Despite the marketed shift to BPA-free products, bisphenol body burden has not meaningfully declined in population monitoring data.
Where it hides in your home
Key research
Eladak et al. A new chapter in the BPA story
Published in Fertility and Sterility: demonstrated BPS and BPF have similar endocrine-disrupting effects to BPA in human and animal testis tissue.
Rochester and Bolden BPA Alternatives Review
Published in Environmental Health Perspectives: systematic review finding BPS and BPF to have similar or greater hormonal activity compared to BPA.
CDC NHANES BPS/BPF Biomonitoring
National biomonitoring data showing BPS detectable in 81% of Americans and BPF in 67%, confirming widespread exposure following the BPA phase-out.
Like BPA, bisphenol alternatives are metabolised relatively quickly. However, constant re-exposure through food packaging, thermal receipt paper, and plastic containers maintains chronic background levels. Switching to glass and stainless steel food storage eliminates the primary source.